Decreasing the thresholds for electroporation by sensitizing cells with local cationic anesthetics and substances that decrease the surface negative electric charge by Grys, Maciej et al.
 
 
CELLULAR & MOLECULAR BIOLOGY LETTERS 
http://www.cmbl.org.pl  
                                                                                                    
Received:  04 July 2013 Volume 19 (2014) pp 65-76 
Final form accepted: 02 January 2014                             DOI: 10.2478/s11658-013-0114-z 
Published online: January 2014                                       ©  2013 by the University of Wrocław, Poland 
 
 
* Authors for correspondence. e-mail: w.korohoda@uj.edu.pl, tel.: + 48 12 664 61 25, fax: 
+48 12 664 69 02; e-mail: z.madeja@uj.edu.pl, tel.: + 48 12 664 61 42 
  
Abbreviations used: 9-AAA – 9-aminoacridine; dcEF – direct current electric field; EthBr2 
– ethidium bromide; FBS – fetal bovine serum; FDA – fluorescein diacetate; HSF – human 
skin fibroblasts; IRE – irreversible electroporation; PBS – phosphate buffered saline with 






DECREASING THE THRESHOLDS FOR ELECTROPORATION  
BY SENSITIZING CELLS WITH LOCAL CATIONIC ANESTHETICS 
AND SUBSTANCES THAT DECREASE THE SURFACE NEGATIVE 
ELECTRIC CHARGE  
 
MACIEJ GRYS, ZBIGNIEW MADEJA* and WŁODZIMIERZ KOROHODA* 
Department of Cell Biology, Faculty of Biochemistry, Biophysics and 
Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387, Kraków, Poland 
 
 
Abstract: The recently described method of cell electroporation by flow of cell 
suspension through localized direct current electric fields (dcEFs) was applied to 
identify non-toxic substances that could sensitize cells to external electric fields. 
We found that local cationic anesthetics such as procaine, lidocaine and 
tetracaine greatly facilitated the electroporation of AT2 rat prostate carcinoma 
cells and human skin fibroblasts (HSF). This manifested as a 50% reduction in 
the strength of the electric field required to induce cell death by irreversible 
electroporation or to introduce fluorescent dyes such as calcein, 
carboxyfluorescein or Lucifer yellow into the cells. A similar decrease in the 
electric field thresholds for irreversible and reversible cell electroporation was 
observed when the cells were exposed to the electric field in the presence of the 
non-toxic cationic dyes 9-aminoacridine (9-AAA) or toluidine blue. Identifying 
non-toxic, reversibly acting cell sensitizers may facilitate cancer tissue ablation 
and help introduce therapeutic or diagnostic substances into the cells and tissues. 
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In the past few decades, reversible electroporation (RE) has been broadly used to 
introduce substances that normally do not penetrate the cell membrane, such as 
dyes, drugs, proteins and nucleic acids, into cells [1-3]. Since 2005, the non-
thermal killing of cells via irreversible electroporation (IRE) has been used to 
ablate neoplastic tissue without scar formation and local bleeding [4-6].  
The aim of this study was to identify substances that affect the properties of the 
cell membrane in such a way as to allow a reduction in the electric field strength 
required for effective RE and IRE. The previously reported method involved cell 
sensitization by hypotonic shock-facilitated electroporation of cultured cells [8], 
but there were a number of methodological constraints to its application in vivo. 
Another method recently described by Pakhomova et al. [9] involved 
sensitization of melanoma B16 and CHO cells by splitting eight 100 µs pulses 
into two trains of four pulses, separated by a 5-min interval. This approach was 
shown to facilitate the uptake of bleomycin and propidium iodide by the cells.  
We used the recently described the method of cell electroporation using a flow 
of cell suspension through a localized electric field [10] to examine the effects of 
substances known to modify cell membrane properties. This method allows the 
numbers of reversibly and irreversibly electroporated cells to be determined as  
a function of dcEF applied to the cells for a given period of time (time duration). 
This method also allows quantitative evaluation of the effects of drugs that are 
introduced through the electroporation solution and are known to modify cell 
membrane properties, on the threshold values of dcEFs and the duration of cell 
exposure required for IRE and RE. 
Surgical procedures are usually carried out with the aid of common local 
anesthetics, such as procaine, lidocaine or tetracaine. These substances not only 
act on neurons but also affect the surrounding cells and tissues. Modulation of 
cell membrane properties can affect a variety of cell functions [11, 12]. External 
dcEFs act on cells interacting with cell membranes. The electric charge on the 
cell membrane is known to influence the physical and chemical properties of the 
cell membranes and can be expected to affect the cell responses to dcEFs acting 
on cells. In particular, the cationic local anesthetics procaine and lidocaine were 
shown to influence the electric charge on cell surfaces as determined with cell 
electrophoresis [13]. Therefore, in our experiments we examined the effects of 
local cationic anesthetics on cell sensitivity to dcEFs causing IRE and RE. These 
substances are harmless for cells and can be selectively and locally applied to the 
chosen cells or tissues, which is of potential significance in clinical practice. 
Here, we identify a few substances that sensitize cells and decrease the threshold 
values of dcEFs required for effective IRE and RE. The experiments were 
carried out on a rat prostate cell line and human skin fibroblasts (HSF) using 
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MATERIAL AND METHODS 
 
Chemicals 
9-Aminoacridine (9-AAA), ethidium bromide, diacetate fluorescein, Alexa Fluor 
488 Phalloidin, gentamicin, calcein, lidocaine HCl, Lucifer yellow, procaine 
HCl, tetracaine HCl, toluidine blue and trypsin-EDTA were all obtained from 
Sigma. Fetal bovine serum (FBS) was from Gibco, Invitrogen. 
Carboxyfluorescein was from Fluka-biochemist, culture medium RPMI 1640 
with L-glutamine from Lonza, NaCl and sucrose from Merck, and PBS without 
calcium and magnesium ions and PBS with calcium and magnesium ions 
(composed of: CaCl2 – 9 µM, MgCl2 – 1 mM, KH2PO4 – 1.5 mM, Na2HPO4@12 
H2O – 7.5 mM, KCl – 2.7 mM, NaCl – 138 mM) were from Biomed. 
 
Cells 
Experiments were carried out on the well-characterized AT-2 rat prostate cancer 
cell line grown in 25-cm2 flasks (Sarstead) as described previously [14]. For 
some experiments, normal human skin fibroblasts (HSF) were used [15]. Before 
electroporation, cells were washed in Ca2+- and Mg2+-free PBS by centrifugation 
and suspended in an electroporation solution. The electroporation solution was 
9.5% sucrose and PBS with Ca and Mg in the ratio 19:1, unless stated otherwise. 
In the cell sensitization experiments, the cells were incubated in electroporation 
solution containing various concentrations of lidocaine HCl, procaine HCl, 
tetracaine HCl, 9-AAA or toluidine blue for 10 min. Following the incubation, 
the cells were centrifuged for the second time and re-suspended in the 
electroporation solution.  
 
Cell electroporation and viability examination 
Cell electroporation was carried out with the setup described in [10], in  
a solution containing calcein, carboxyfluorescein or Lucifer yellow. The 
effectiveness of the method was established by scoring the number of 
fluorescent cells found 15-30 min following the procedure.  
A fluorescent viability test using fluorescein diacetate (FDA) and ethidium 
bromide (EthBr2) was carried out to determine the number of live cells [10, 16-20]. 
During the electroporation procedure, the electroporated cells remained in the 
electroporation medium with or without added substances for no more than one 
hour. Then the cells were transferred either to PBS or to the cell culture medium 
for examination under a fluorescence microscope. In each experiment, 1250 to 
2250 cells were examined under a Jenavert epi-fluorescent microscope (Carl 
Zeiss Jena) to determine the effect of established exposure time on cells of the 
dcEFs. At least 250 cells were observed to determine the position of one point in 
the plot. The FDA/EthBr2 iodide test was applied. Green fluorescent cells were 
counted as alive and red fluorescent cells as dead. The cells that showed the 
uptake of calcein, carboxyfluorescein or Lucifer yellow were counted as 
reversibly electroporated, while the cells that were not fluorescent were counted 
as not reversibly electroporated. All of the curves presented in Figs 1-4 were 
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drawn as matched with experimentally determined points. The values of LD50 
and ED50 were calculated with Stephen Wolfram’s Mathematica program.  
In experiments testing the effects of local anesthetics on the RE and IRE 
thresholds, the drugs were applied at much lower concentrations than used in 
clinical practice. For example, in order to obtain a local anesthesia lasting for  
1 to 3 h, procaine HCl and lidocaine HCl are used at concentrations of 1 to 2%, 
while tetracaine is used at 0.05 to 0.5%. In our experiments, we used procaine 
HCl and lidocaine HCl at 10 mM concentration and tetracaine at 0.6 mM 
(corresponding to concentrations of 0.2% and 0.02%, respectively). One 
experiment carried out to electroporate the cells at given time of cell exposure to 
dcEFs lasted less than 1 h. The efficiency of RE or IRE as a function of dcEFs 





We applied the recently described method of cell electroporation by flow of cell 
suspension through a localized electric field [10]. The experiments were carried 
out on a rat prostate cell line and human skin fibroblasts (HSF) using anesthetics 
at lower concentrations than commonly used for surgical anesthesia.  
The cationic anesthetics procaine HCl and lidocaine HCl were present in the 
electroporation medium at a concentration of 10 mM and tetracaine was present 
at 0.6 mM (corresponding to concentrations of 0.2% and 0.02%, respectively). 
Such exposure had no effect on the viability or uptake of the used fluorescent 
dyes in cells incubated for 1 h in their presence and not electroporated. More 
than 90% of the cells remained alive and unloaded with fluorescent dyes. 
Toluidine blue present at 15 µM and 9-AAA at 30 µM also had no effect on cell 
viability. In other experiments on the morphology, proliferation and movement 
of various cells grown for days in the presence of substances tested in these 
experiments, procaine HCl was found to have the least influence (data not shown). 
The experiments demonstrated that all three tested local cationic anesthetics 
significantly decreased the dcEF strength required for effective IRE in AT2 
cells. Fig. 1A-C show the percentage of AT2 cells killed by the exposure to 
dcEFs in the range 300 to 1200 V/cm for 0.62 s (IRE) in the electroporation 
medium alone (control) and in the electroporation medium supplemented with 
added local cationic anesthetics, 9-AAA or toluidine blue.  
All three tested anesthetics significantly decreased the dcEF strength required 
for the effective IRE in AT2 cells (Fig. 1A, B). As shown in Fig. 1A, 10 mM 
procaine HCl caused a decrease in the LD50 dcEF from 784 to 426 V/cm. The 
two cell viability tests (the calcein [10, 20, 21] and FDA/ethidium bromide tests 
[18]) gave compatible results.  
We then studied the effects of the cationic local anesthetics tetracaine, procaine 
and lidocaine on cell viability using the calcein uptake test. Tetracaine was used 
at a concentration of 0.6 mM since higher concentrations decreased cell viability  
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Fig. 1. Irreversible electroporation with cationic local anesthetics or cationic dyes was used 
to decrease the threshold values of dcEFs that cause non-thermal cell killing of AT2 cells. 
A – The effect of procaine on the viability of AT2 cells exposed to dcEF for 0.62 s. 
Viability was examined using the FDA/ethidium bromide test and the calcein uptake test. 
X-axis – dcEF in V/cm, Y-axis – percentage of viable cells as a function of dcEF strength 
(calcein-loaded cells – control LD50 = 784 V/cm; LD50 in the presence of 10 mM procaine 
= 426 V/cm). B – Cationic local anesthetics (procaine, lidocaine, and tetracaine) decrease 
the threshold values of dcEFs that cause non-thermal cell killing by irreversible 
electroporation (calcein-loaded cells – control LD50 = 784 V/cm; LD50 in the presence of 
0.6 mM tetracaine = 543 V/cm; LD50 in the presence of 10 mM procaine = 426 V/cm; LD50 
in the presence of 10 mM lidocaine = 482 V/cm). Cell viability was determined using the 
calcein test. C – The effects of cationic dyes (9-aminoacridine and toluidine blue) on the 
decrease in the threshold values of dcEFs that cause cell killing by irreversible 
electroporation (calcein-loaded cells – control LD50 = 784 V/cm; LD50 in the presence of 
30 µM 9-AAA = 519 V/cm; LD50 in the presence of 15 µM toluidine blue = 397 V/cm). 
Cell viability was determined with the calcein test.  
 
after 1 h incubation. The results are shown in Fig. 1B. Both lidocaine and 
tetracaine also significantly decreased the threshold values of dcEFs required for 
IRE, when compared with the values of dcEFs required for cell killing by IRE in 
the control experiments in the absence of the tested cationic anesthetics. 
Next, we tested whether other non-toxic cationic substances, such as toluidine 
blue (15 uM) [13] or 9-AAA (30 µM) [22, 23], would influence the threshold 
values of dcEFs required for cell killing by IRE. Toluidine blue was more 
effective than procaine but caused some calcein leakage from calcein-loaded 
cells if they were later incubated in its presence for 1 to 3 h. The values of LD50 
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in the control experiments without the addition of tested sensitizers and in their 
presence are included in the legends to the figures. 
In a previous study [10], we found that briefly exposing cells to dcEF allowed 
for more effective calcein loading and that cell viability was improved when 
exposure to dcEFs did not exceed 0.1 s. Therefore, in order to introduce 
fluorescent dyes that normally do not permeate cell membranes, we applied 
single exposures to dcEFs lasting for 0.08 s. The results are shown in Fig. 2A.  
A dcEF of 50 V/cm was sufficient to load approximately 90% of AT-2 cells with 
calcein in the presence of procaine, whereas in the control experiments without 
procaine, a dcEF of 400 V/cm was required (Fig. 3). The cells flowing through 
the system but not exposed to dcEFs were not loaded with the fluorescent dyes 
(0 dcEF strength). Lidocaine and tetracaine also decreased the dcEFs required 
for calcein loading but were less effective than procaine. In the presence of 
cationic dyes that decrease the negative electric charge on the cell surface 
(toluidine blue and 9-AAA), the uptake of calcein by AT2 cells required much lower 
dcEFs than in the control experiments with the cells electroporated in the 




Fig. 2. Decreased dcEF strength is required for the uptake of calcein by AT2 cells when 
cationic anesthetics or cationic dyes are used. A – The effect of the supplementation of the 
electroporation solution with local cationic anesthetics (procaine, lidocaine and tetracaine) 
on the dcEF strength required for the uptake of calcein by AT2 cells after a single 0.08 s 
exposure to dcEFs (ED50 for calcein-loaded cells under control conditions = 100 V/cm; 
ED50 in the presence of 10 mM procaine is 7 V/cm; ED50 in the presence of 0.6 mM 
tetracaine = 18 V/cm; ED50 in the presence of 10 mM lidocaine = 38 V/cm). B – The effect 
of cationic dyes (aminoacridine and toluidine blue) on the sensitization of cells to dcEFs 
and decrease in dcEF strength required for loading cells with calcein (ED50 for calcein-
loaded cells under control conditions = 100 V/cm; ED50 in the presence of 30 µM 9-AAA 
= 9 V/cm; ED50 in the presence of 15 µM toluidine blue = 8 V/cm). The dcEFs in the range 
0 to 300 V/cm were examined. Other notations as in Fig. 1A. 
 
The effects of anesthetics on calcein and carboxyfluorescein loading of cells 
were identical (data not shown). Interestingly, the threshold values of dcEFs 
required for loading of cells with Lucifer yellow were lower than those required 
for calcein loading and were further decreased in the presence of procaine  
(Fig. 3A and B). 
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Fig. 3. The effect of procaine on AT2 prostate cancer cell loading with calcein or Lucifer 
yellow following a single 0.08 s exposure to dcEF. A – Cells loaded with calcein (ED50 
under control conditions = 161 V/cm; ED50 in the presence of 10 mM procaine = 7 V/cm). 
B – Cells loaded with Lucifer yellow (ED50 under control conditions = 34 V/cm; ED50 in 
the presence of 10 mM procaine = 7 V/cm). The dcEFs in the range 0 to 1 000 V/cm were 
examined. Other notations as in Fig. 1A. 
 
In our previous study [10], we found that the human skin fibroblasts are much 
more sensitive to IRE and RE than AT2 cancer prostate cells or human red blood 
cells. Fig. 4 shows that the presence of 10 mM procaine in the electroporation 
solution decreased the thresholds of dcEFs required for RE and IRE in human 
skin fibroblasts (HSF) after an 0.08 s exposure. The fibroblasts were so strongly 
sensitized to electric fields in the presence of procaine that the 0.08 s exposure of these 
cells to a dcEF of 10-20 V/cm appeared sufficient to load the cells with calcein, and 




Fig. 4. Calcein loading of AT2 prostate cancer cells and human skin fibroblasts (HSF) after 
a single exposure to dcEF for 0.08 s in the presence and in the absence (control) of 
procaine in the electroporation medium. ED50 for calcein-loaded AT2 cells under control 
conditions = 161 V/cm. ED50 for calcein-loaded AT2 cells in the presence of 10 mM 
procaine = 7 V/cm. ED50 for calcein-loaded HSF cells under control conditions = 7 V/cm. 
ED50 for calcein-loaded HSF cells in the presence of 10 mM procaine = 6 V/cm. The 
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Our recently described method of cell electroporation involves equipment 
commonly used for electrophoresis and shows versatility. It permits the 
determination of cell sensitivity to external electric fields under controlled 
experimental conditions [10]. In 2004 and 2011, we examined the applicability 
of the method using a short exposure of a flowing suspension of cells through  
a focused dcEF to study the survival of Dictyostelium discoideum and tissue 
culture cells as a function of electric field strength and time of exposure 
(unpublished results). To facilitate the delivery of substances into the cells and 
improve cell viability following the procedure, the cells had to remain in contact 
with the tested substances during and after the electroporation. This was 
achieved by the flow of cell suspension within the narrow tube and elimination 
of the action of electrode products on the cells, as previously described [10]. 
Independently, Geng et al. [24, 25] demonstrated an efficient transfection of 
Chinese hamster ovary cells with plasmids encoding green fluorescent protein 
by flow through a chip device ensuring a repeated exposure of cells to focused 
constant voltage electric fields, corresponding to the series of electric pulses.  
We examined the effects of a single exposure of cells to dcEFs in the presence of 
various substances modifying cell membrane properties. This approach yields 
results that are more unequivocal and can be more easily interpreted than those 
from a series of electric pulses or exposures to an external electric field [8]. In 
this case, the time interval between the exposures to the strong electric field has 
great impact on cell responses [9]. The method described in this study greatly 
improves cell viability following electroporation and sensitizes cells to non-
thermal cell killing by exposure to dcEFs. 
The results presented here show that local cationic anesthetics commonly used in 
medicine, such as procaine, lidocaine or tetracaine, allow a 50% reduction in the 
strength of dcEFs required for effective IRE or RE. These effects are observed 
when the anesthetics are applied at concentrations much lower than used in the 
clinical practice. Though lidocaine appears to be the most often used local 
anesthetic, we observed that procaine was more effective in decreasing dcEF 
threshold values required for cell electroporation and preserving cell viability 
during and after the procedure. A similar decrease in electric field strength 
threshold values for IRE and RE was also observed for cationic dyes toluidine 
blue and 9-AAA used at non-toxic concentrations.  
The local anesthetics procaine, lidocaine, and tetracaine induce changes in the 
cell membrane properties and functions in non-neuronal cells [11, 12], including 
changes in the cell surface charge and changes in the cell electrophoretic 
mobility [13]. Decreasing the charge density can greatly affect the physical 
properties of the cell membrane. Changes in protein conformation and 
phospholipid liquid crystal structure caused by cationic substances can sensitize 
cells to dcEFs, increasing the effectiveness of RE and IRE [27]. In support of 
this hypothesis, we observed that the substances that reduce the negative charge 
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of the cell surface [22, 23], such as 9-AAA and toluidine blue, also decreased the 
dcEFs required for IRE and RE. The precise mechanism of the effects induced 
by local anesthetics will require further study. 
Our experiments described in this report were inspired by two groups of 
observations. First, the thresholds of dcEFs for RE and IRE depend on the cell 
size [10, 27-29]. Even when the cell size effect is eliminated and the threshold 
values of electric field strength are expressed in V/cell diameter, the differences 
in the sensitivity of various cell types are preserved [10]. This suggests that the 
cell membrane properties significantly influence cell sensitivity to dcEFs.  
Second, in the 1960s, on the grounds of the theory of flexible electrolytes, it was 
discussed how changes in the membrane surface electric charge density 
influence dynamic membrane properties, leading to pore formation [30, 31]. It 
was suggested that changes in the electric charge on the cell surface may modify 
the physical and chemical properties of the cell membrane and affect its 
interactions with external electric fields and other surfaces [30, 32]. Gingell [33] 
demonstrated that a non-specific decrease in the negative electric charge on the 
surface of Xenopus laevis eggs introduced by adsorption of polycations, induced 
changes in the membrane organization, manifested by increased membrane 
permeability. This in turn caused contractile responses in the cortical cytoplasm 
of Xenopus laevis eggs. It was observed that the non-thermal break in the 
membrane of cells placed in strong dcEFs always took place at the cell pole 
directed to the anode [34] and that the same part of the cell showed contraction 
during cell galvanotaxis in weak dcEFs [35]. More recently, Teissié [36] founds 
that the cell reversible electroporation (RE) also starts at the cell end directed to 
anode. In addition, it is known that coating DNA with cationic substances 
improves the effectiveness of transfection [37, 38]. 
The findings described in this study may find application in clinical practice. 
Identification of non-toxic, reversibly acting cell sensitizers may facilitate cancer 
tissue ablation and help introduce therapeutic or diagnostic substances into the 
cells and tissues. The discovery of cell sensitizers for light significantly 
increased the effectiveness of phototherapy [39, 40] and temperature sensitizers 
are likely to improve thermotherapy in oncology [41, 42]. One can expect that 
the results presented here will stimulate further search for cell sensitizers and 
help open new avenues for the application of RE and IRE in biotechnology and 
medicine.  
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